Verition Fund Management LLC acquired a new stake in Astera Labs, Inc. (NASDAQ:ALAB - Free Report) in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund acquired 29,091 shares of the company's stock, valued at approximately $1,524,000.
Other institutional investors and hedge funds also recently bought and sold shares of the company. Great Valley Advisor Group Inc. bought a new stake in shares of Astera Labs during the second quarter valued at approximately $443,000. Bank of New York Mellon Corp acquired a new stake in shares of Astera Labs in the 2nd quarter valued at $8,361,000. Legato Capital Management LLC bought a new stake in shares of Astera Labs during the second quarter worth $207,000. Strategic Blueprint LLC acquired a new position in shares of Astera Labs during the second quarter valued at $332,000. Finally, Essex Financial Services Inc. bought a new position in Astera Labs in the second quarter valued at about $1,304,000.
Analyst Upgrades and Downgrades
Several analysts have weighed in on the company. Roth Mkm boosted their price objective on Astera Labs from $80.00 to $105.00 and gave the stock a "buy" rating in a report on Tuesday, November 5th. Craig Hallum increased their price objective on shares of Astera Labs from $75.00 to $105.00 and gave the company a "buy" rating in a report on Tuesday, November 5th. Stifel Nicolaus lifted their target price on shares of Astera Labs from $80.00 to $100.00 and gave the stock a "buy" rating in a report on Tuesday, November 5th. JPMorgan Chase & Co. increased their price target on Astera Labs from $70.00 to $110.00 and gave the company an "overweight" rating in a research note on Tuesday, November 5th. Finally, Morgan Stanley lifted their price objective on Astera Labs from $74.00 to $94.00 and gave the stock an "overweight" rating in a research note on Tuesday, November 5th. Twelve research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock presently has a consensus rating of "Buy" and an average target price of $94.67.
Read Our Latest Stock Analysis on Astera Labs
Astera Labs Stock Performance
ALAB stock traded up $5.72 during mid-day trading on Friday, hitting $120.40. 4,065,807 shares of the company were exchanged, compared to its average volume of 5,095,545. Astera Labs, Inc. has a 1-year low of $36.22 and a 1-year high of $121.20. The firm's 50 day simple moving average is $81.38 and its 200 day simple moving average is $62.40.
Astera Labs (NASDAQ:ALAB - Get Free Report) last announced its earnings results on Monday, November 4th. The company reported $0.23 earnings per share for the quarter, topping analysts' consensus estimates of $0.17 by $0.06. Astera Labs had a negative net margin of 30.69% and a negative return on equity of 15.57%. The firm had revenue of $113.10 million during the quarter, compared to analyst estimates of $97.50 million. The firm's revenue was up 47.1% on a year-over-year basis. On average, analysts expect that Astera Labs, Inc. will post -0.45 earnings per share for the current fiscal year.
Insider Buying and Selling at Astera Labs
In related news, insider Sanjay Gajendra sold 76,701 shares of the company's stock in a transaction dated Tuesday, September 17th. The stock was sold at an average price of $45.32, for a total transaction of $3,476,089.32. Following the sale, the insider now owns 855,000 shares in the company, valued at approximately $38,748,600. This represents a 8.23 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Manuel Alba sold 11,000 shares of the stock in a transaction that occurred on Wednesday, December 4th. The shares were sold at an average price of $117.50, for a total value of $1,292,500.00. Following the transaction, the director now directly owns 456,863 shares of the company's stock, valued at $53,681,402.50. This trade represents a 2.35 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 2,154,820 shares of company stock worth $195,106,438.
Astera Labs Profile
(
Free Report)
Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
Further Reading
Before you consider Astera Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.
While Astera Labs currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.